Alphatec Announces Commercial Launch of the InVictus™ MIS and Open Spinal Fixation Systems
23 July 2019 - 11:00PM
Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a
medical device company dedicated to revolutionizing the approach to
spine surgery, announced today the commercial release of InVictus™,
a comprehensive spinal fixation platform designed to address a
range of pathologies through a minimally invasive (MIS), open, or
hybrid surgical approach.
“The InVictus platform incorporates and improves
upon the learnings and know-how of a team with unmatched expertise
in the field of posterior fixation,” said Pat Miles, Chairman and
Chief Executive Officer. “InVictus will be the foundation for
ATEC’s thoracolumbar surgical approaches and is a proxy for the
sophistication that will be reflected across the entire ATEC
portfolio. We are witnessing the unleashing of Spine’s new
Organic Innovation Machine.”
With the introduction of the InVictus systems,
ATEC has launched seven of twelve products planned for 2019.
InVictus MIS and Open
Spinal Fixation Systems
The launch of the InVictus MIS and Open Fixation
Systems follow successful evaluations that began in November
2018.
As one of the market’s most comprehensive
thoracolumbar fixation platforms, InVictus is designed to provide
enhanced strength, adaptability, and predictability compared to
previously available fixation systems. InVictus is designed
to enable surgeons to customize surgical treatments to meet the
clinical needs of each patient. The platform integrates
seamlessly with SafeOp neurophysiology to provide objective,
actionable, real-time information throughout the procedure for
safer and more reproducible spine surgery.
“The level of experience and know-how of the
internal design team is evident in every detail as it relates to
the implants and instruments,” said Gurvinder S. Deol, M.D. of Wake
Orthopaedics in Raleigh, North Carolina. “From the unique
InVictus thread pattern to the various reduction options, this
sophistication results in excellent intraoperative adaptability,
allowing me to tailor my approach to suit each patient.
Integrating technologies like SafeOp into the InVictus platform
provides real-time neural health feedback, and drives increased
safety and better outcomes.”
Timothy R. Kuklo, M.D. of Denver International
Spine Center in Colorado added, “My practice consists of adult
degenerative pathology to adolescent and adult deformity.
Having one reliable system that my team and I can utilize in all
cases leads to more predictable outcomes, whether it’s an open,
MIS, or hybrid approach.”
Key Features of the InVictus MIS and
Open Fixation Systems
ATEC’s InVictus Comprehensive Spinal Fixation
Platform has been designed to improve surgical outcomes across a
range of degenerative and complex deformity thoracolumbar
pathologies, even in the most challenging procedural
scenarios. Paired with AlphaInformatiX technologies, InVictus
is capable of seamlessly crossing the cervical-thoracic junction
and integrating posterior approach systems.
Key features include:
- Biomechanical strength necessary to achieve a solid
fusion;
- Unique lock screw design to enhance dependability by reducing
head splay and cross threading;
- Wide variety of low-profile implants that accept multiple rod
diameters; and
- Ergonomically designed instrumentation, designed to improve
surgical predictability and comfort during complex surgeries.
About Alphatec Holdings,
Inc.
Alphatec Holdings, Inc., through its
wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp
Surgical, Inc., is a medical device company dedicated to
revolutionizing the approach to spine surgery. ATEC designs,
develops and markets spinal fusion technology products and
solutions for the treatment of spinal disorders associated with
disease and degeneration, congenital deformities and trauma.
The Company markets its products in the U.S. via independent sales
agents and a direct sales force.
Additional information can be found at
www.atecspine.com.
Forward Looking Statements
This press release contains "forward-looking
statements" within the meaning of the Private Securities Litigation
Reform Act of 1995 that involve risks and uncertainty. Such
statements are based on management's current expectations and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. The Company cautions investors that
there can be no assurance that actual results will not differ
materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include references to the Company’s
planned commercial launches, product introductions and product
integration, surgeon and market acceptance of Company products,
solutions and platforms, and the Company’s ability to deliver key
product features. The important factors that could cause
actual operating results to differ significantly from those
expressed or implied by such forward-looking statements include,
but are not limited to: the uncertainty of success in developing
new products or products currently in the Company’s pipeline;
failure to achieve acceptance of the Company’s products by the
surgeon community; failure to obtain FDA or other
regulatory clearance or approval for new products, or unexpected or
prolonged delays in the process; continuation of favorable third
party reimbursement for procedures performed using the Company’s
products; the Company’s ability to compete with other products and
with emerging new technologies; product liability exposure; patent
infringement claims; and claims related to the Company’s
intellectual property. The words “believe,” “will,” “should,”
“expect,” “intend,” “estimate,” “look forward” and “anticipate,”
variations of such words and similar expressions identify
forward-looking statements, but their absence does not mean that a
statement is not a forward-looking statement. A further list
and description of these and other factors, risks and uncertainties
can be found in the Company's most recent annual report, and any
subsequent quarterly and current reports, filed with
the Securities and Exchange Commission. ATEC disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
Investor/Media Contact:
Tina JacobsenInvestor Relations (760)
494-6790ir@atecspine.com
Company Contact:
Jeff BlackChief Financial OfficerAlphatec
Holdings, Inc. ir@atecspine.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/b0e16c5f-a1cb-4c7a-a4d5-82ae6fa86638
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Apr 2024 to May 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From May 2023 to May 2024